74938-2 |
Lidocaine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Lidocaine [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74938-2 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Lidocain Trough SerPl-mCnc |
|
|
|
|
|
c232; c251; CLID; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xylocaine |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
74939-0 |
Vigabatrin^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Vigabatrin [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74939-0 |
|
|
|
|
Both |
|
|
|
0 |
Vigabatrin Trough SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; Sabril; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
7494-8 |
Panicum milliaceum Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Common Millet IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
7494-8 |
|
|
|
|
Both |
|
|
|
0 |
Common Millet IgG Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Common millet; f055; f55; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
1.0h(2) |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
74940-8 |
Moclobemide^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Moclobemide [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74940-8 |
|
|
|
|
Both |
|
|
|
0 |
Moclobemide Trough SerPl-mCnc |
|
|
|
|
|
Aurorix; DRUG/TOXICOLOGY; Drugs; Level; Manerix; Mass concentration; MOC; Moclamine; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
74941-6 |
Moclobemide |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Moclobemide [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74941-6 |
|
|
|
|
Both |
|
|
|
0 |
Moclobemide SerPl-mCnc |
|
|
|
|
|
Aurorix; DRUG/TOXICOLOGY; Drugs; Level; Manerix; Mass concentration; MOC; Moclamine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
74942-4 |
Kynurenin |
SCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Kynurenin [Moles/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
74942-4 |
|
|
|
|
Both |
|
|
|
0 |
Kynurenin CSF-sCnc |
|
|
|
|
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Kynurenine; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Substance concentration |
2.48 |
2.48 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
74943-2 |
busPIRone^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
busPIRone [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74943-2 |
|
|
|
|
Both |
|
|
|
0 |
busPIRone Trough SerPl-mCnc |
|
|
|
|
|
Buspar; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
74944-0 |
lamoTRIgine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
lamoTRIgine [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
74944-0 |
|
|
|
|
Both |
|
|
|
0 |
lamoTRIgine Trough SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Lamictal; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
74945-7 |
clomiPRAMINE+Norclomipramine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
clomiPRAMINE+Norclomipramine [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74945-7 |
|
|
|
|
Both |
|
|
|
0 |
clomiPRAMINE+Nor Trough SerPl-mCnc |
|
|
|
|
|
Anafranil; Anofranil; Clom; Clomip; Clomipramine metabolite; Desmeth; Desmethylclomip; Desmethylclomipramine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.69 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
Release 2.69: COMPONENT: Added TALLMAN lettering; |
0 |
74946-5 |
Normirtazapine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Normirtazapine [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
74946-5 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Normirtazapine Trough SerPl-m |
|
|
|
|
|
Desmethylmirtazapine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mirtazapine metabolite; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
74947-3 |
Norclomipramine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Norclomipramine [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74947-3 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Norclomipramine Trough SerPl- |
|
|
|
|
|
Clomipramine metabolite; Desmeth; Desmethylclomip; Desmethylclomipramine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
74948-1 |
Fluoxetine+Norfluoxetine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
FLUoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74948-1 |
|
|
|
|
Both |
|
|
|
0 |
FLUoxetine+Nor Trough SerPl-mCnc |
|
|
|
|
|
(S)-Norfluoxetine; Desmethylfluoxetine; DRUG/TOXICOLOGY; Drugs; Fluoxetine metabolite; Level; Mass concentration; Norfluoxetin; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; Prozac; QNT; Quan; Quant; Quantitative; Random; Seproxetine; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.54 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
74949-9 |
Perphenazine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Perphenazine [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74949-9 |
|
|
|
|
Both |
|
|
|
0 |
Perphenazine Trough SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trilafon |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
7495-5 |
Mite dust Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Mite dust IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
7495-5 |
|
|
|
|
Both |
|
|
|
0 |
Mite Dust IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Mites; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
74950-7 |
Galactocerebrosidase |
CCnt |
WBC |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Galactocerebrosidase [Enzymatic activity/mass] in Leukocytes |
|
DEL |
DefinitionDescription |
|
|
nmol/h/mg protein |
|
|
|
|
|
|
CHEM |
|
74950-7 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Galactocerebrosidase WBC-cCnt |
|
|
|
|
|
Catalytic Content; Chemistry; Galactosylceramidase; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells |
2.52 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
74951-5 |
E-10-Hydroxynortriptyline^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated E-10-Hydroxynortriptyline [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74951-5 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated E-10-OH-NT Trough SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; E-10-OH-NT; Level; Mass concentration; Nortriptyline metabolite; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
74952-3 |
Lymphocyte proliferation |
Imp |
Bld |
Pt |
Nar |
|
|
ACTIVE |
Lymphocyte proliferation [Interpretation] in Blood Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
74952-3 |
|
|
|
|
Observation |
|
|
|
0 |
Lymphocyte prolif Bld-Imp Nar |
|
|
|
|
|
Blood; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; LPA; LPT; LST; Lymphocyte antigen proliferation; Lymphocyte antigen stimulation; Narrative; PHA; Point in time; Random; Report; Serology; WB; Whole blood |
2.5 |
2.48 |
|
|
|
|
|
|
|
|
|
|
|
0 |
74953-1 |
Macroprolactin |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Macroprolactin [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
74953-1 |
|
|
|
|
Both |
|
|
|
0 |
Macroprolactin SerPl-aCnc |
|
|
|
|
|
Arbitrary concentration; bbPRL; Big-big prolactin; Chemistry; IgG-bound Prolactin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
|
0 |
74954-9 |
Isomaltase |
CCnt |
Tsmi |
Pt |
Qn |
|
|
ACTIVE |
Isomaltase [Enzymatic activity/mass] in Small intestine Tissue |
|
MIN |
DefinitionDescription |
|
|
umol/min/g |
|
|
|
|
|
|
CHEM |
|
74954-9 |
|
|
|
|
Both |
|
|
|
0 |
Isomaltase TSMI-cCnt |
|
|
|
|
|
Alpha dextrinase; Catalytic Content; Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue small intestine |
2.48 |
2.48 |
|
|
|
|
|
|
|
umol/min/g |
|
|
|
0 |
74955-6 |
Cyproheptadine^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Cyproheptadine [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74955-6 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Cyproheptadine Trough SerPl-m |
|
|
|
|
|
C21H21N; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Periactin; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
74956-4 |
chlordiazePOXIDE^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated chlordiazePOXIDE [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74956-4 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Chlordiazep Trough SerPl-mCnc |
|
|
|
|
|
Chlordiaz; Chlordiaze; Chlordiazep; DRUG/TOXICOLOGY; Drugs; Level; Librium; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
74957-2 |
Succinylacetone |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Succinylacetone [Moles/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
74957-2 |
|
|
|
|
Both |
|
|
|
0 |
Succinylacetone Plas-sCnc |
|
|
|
|
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SA; SUAC; Substance concentration |
2.48 |
2.48 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
74958-0 |
clomiPRAMINE^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
clomiPRAMINE [Mass/volume] in Serum or Plasma --trough |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74958-0 |
|
|
|
|
Both |
|
|
|
0 |
clomiPRAMINE Trough SerPl-mCnc |
|
|
|
|
|
Anafranil; Anofranil; Clom; Clomip; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.48 |
2.48 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
74959-8 |
fluvoxaMINE^trough |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated fluvoxaMINE [Mass/volume] in Serum or Plasma --trough |
|
DEL |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
74959-8 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated fluvoxaMINE Trough SerPl-mCnc |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Level; Luvox; Mass concentration; Pl; Plasma; Plsm; Point in time; Pre; Predose; Pre-dose; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.54 |
2.48 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
7496-3 |
Cheese mold type Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Cheese mold type IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
7496-3 |
|
|
|
|
Both |
|
|
|
0 |
Cheese Mold IgG Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f082; f82; Immune globulin G; Immunoglobulin G; Mould; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |